During the past decade, Shin Yukuhashi Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shin Yukuhashi Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Shin Yukuhashi Hospital" are "Diabetes Mellitus, Type 2" (1 trials), "Metapneumovirus" (1 trials), "Respiratory Syncytial Virus Infections" (1 trials), "Secondary Prevention" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Shin Yukuhashi Hospital" in a lesser frequency.

Most popular intervention types in "Shin Yukuhashi Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ASA 100 mg" (1 trials), "JNJ-53718678 500 mg" (1 trials), "JNJ-53718678 80 mg" (1 trials) and "Lumicitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shin Yukuhashi Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Shin Yukuhashi Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Shin Yukuhashi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shin Yukuhashi Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".